0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

EXPERIENCES WITH ETHYLHYDROCUPREIN IN THE TREATMENT OF MEASLES, SCARLET FEVER AND OTHER INFECTIONS

ARTHUR D. HIRSCHFELDER; FREDERIC W. SCHLUTZ
Am J Dis Child. 1916;XI(5):361-366. doi:10.1001/archpedi.1916.04110110054006.
Text Size: A A A
Published online

The studies of Morgenroth and his collaborators have shown that a number of quinin derivations manifest considerable curative powers against trypanosomes, spirochetes and pneumococci, and that this power reaches its maximum in the substance known as ethylhydrocuprein.

Although this drug is very successful in curing mice affected with pneumococcus septicemia, Engwer and also one of us (H.) have been unable to obtain any striking series of cures in guinea-pigs and rabbits with experimental lobar pneumonia, even with the lowest dose (60,000 pairs per cubic millimeter) which is certainly fatal.

This drug has been used with a certain amount of success in clinical pneumonia by Linné and Vetlesen and also locally in cases of pneumococcus keratitis by Ginsberg. Giemsa and Izar have found it a specific in the treatment of stubborn estivo-autumnal malaria cases which have withstood the action of quinin.

Further extension of clinical observation with this drug in other

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();